A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Pediatrix is a leading provider of physician services including newborn, maternal-fetal, and other pediatric subspecialty care. Our national network is comprised of affiliated physicians who provide clinical care in 37 states. During 2024, we formalized our practice portfolio management plans, resulting in a decision to exit almost all of our affiliated office-based practices, other than maternal-fetal medicine. As of December 31, 2024, these plans were completed. Additionally, we exited our primary and urgent care service line during 2024 based on a review of the cost and time that would be required to build the platform to scale. At December 31, 2025, our national network comprised approximately 2,295 affiliated physicians, including 1,350 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (“NICUs”), to babies born prematurely or with medical complications.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.9B | 1.9B | 2.0B | 2.0B | 2.0B | 1.9B |
| Net Income | 165M | 165M | -99M | -60M | 66M | 131M |
| EPS | $1.94 | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 |
| Free Cash Flow | 253M | 253M | 185M | 104M | 137M | 44M |
| ROIC | 13.9% | 15.3% | -7.3% | 0.5% | 8.8% | 11.1% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.76 | 0.76 | 0.89 | 0.84 | 0.82 | 1.18 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 209M | 209M | -69M | 7.3M | 173M | 203M |
| Operating Margin | 10.9% | 10.9% | -3.4% | 0.4% | 8.8% | 10.6% |
| ROE | 19.1% | 20.3% | -13.0% | -7.1% | 7.4% | 14.6% |
| Shares Outstanding | 85M | 85M | 83M | 83M | 84M | 86M |
Pediatrix Medical Group, Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
Pediatrix Medical Group, Inc. trades at 11.2x trailing earnings, compared to its 15-year median P/E of 16.6x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 6.7x vs a median of 9.8x. The company's 5-year average ROIC is 5.7%. Total shareholder yield (buybacks) is 4.7%. At current prices, the estimated annualized return to fair value is -6.2%.
Pediatrix Medical Group, Inc. (MD) has a current P/E ratio of 11.2, compared to its historical median P/E of 16.6. The stock is currently considered Cheap based on its historical valuation range.
Pediatrix Medical Group, Inc. (MD) has a 5-year average return on invested capital (ROIC) of 5.7%. This is below average and may indicate limited pricing power.
Pediatrix Medical Group, Inc. (MD) has a market capitalization of $1.9B. It is classified as a small-cap stock.
Pediatrix Medical Group, Inc. (MD) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 4.66%.
Based on historical P/E analysis, Pediatrix Medical Group, Inc. (MD) appears cheap. The current P/E of 11.2 is 32% below its historical median of 16.6. The estimated fair value CAGR (P/E method) is -15.9%.
Pediatrix Medical Group, Inc. (MD) operates in the Services-Hospitals industry, within the Healthcare sector.
Pediatrix Medical Group, Inc. (MD) reported annual revenue of $1.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
Pediatrix Medical Group, Inc. (MD) has a net profit margin of 8.6%. This is a modest margin.
Pediatrix Medical Group, Inc. (MD) generated $253 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Pediatrix Medical Group, Inc. (MD) has a debt-to-equity ratio of 0.76. This indicates moderate leverage.
Pediatrix Medical Group, Inc. (MD) reported earnings per share (EPS) of $1.94 in its most recent fiscal year.
Pediatrix Medical Group, Inc. (MD) has a return on equity (ROE) of 20.3%. This indicates the company generates strong returns for shareholders.
The Ledger Terminal provides 18 years of financial data for Pediatrix Medical Group, Inc. (MD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Pediatrix Medical Group, Inc. (MD) has a book value per share of $10.16, based on its most recent annual SEC filing.